{"transactions":[{"id":1934242,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T16:21:20.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":7885,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted pursuant to the 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan.  Each RSU represents a contingent right to receive one share of common stock upon the vesting date.  The RSUs vest as follows:  3,943 shares vest on April 15, 2023 and 3,942 shares vest on December 31, 2023. The vesting of the December 31, 2023 RSUs will accelerate upon a Change in Control prior to December 31, 2023."}],"balance_after":12125,"source":{"system":"sec-edgar","filing":"0001578563-23-000012","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000157856323000012/primary_doc.xml","form_type":"4"}},{"id":2223259,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T16:06:41.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":142509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning June 22, 2022, subject to the director's continued service with the Company at each vest date."}],"balance_after":142509,"derivative":{"exercise_price":0.2649,"expiration_date":"2032-06-22","underlying":"Common stock","underlying_shares":142509},"source":{"system":"sec-edgar","filing":"0001551986-22-000059","document":"wf-form4_165601476301026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198622000059/wf-form4_165601476301026.xml","form_type":"4"}},{"id":2348593,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T19:41:06.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the Grant Date."}],"balance_after":11000,"derivative":{"exercise_price":3.71,"expiration_date":"2032-02-28","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001654954-22-002656","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495422002656/section16.xml","form_type":"4"}},{"id":2657712,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T16:15:31.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning June 22, 2021, subject to the director's continued service with the Company at each vest date."}],"balance_after":90000,"derivative":{"exercise_price":1.38,"expiration_date":"2031-06-22","underlying":"Common stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001551986-21-000077","document":"wf-form4_162447931139453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198621000077/wf-form4_162447931139453.xml","form_type":"4"}},{"id":2739850,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T17:04:13.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the Grant Date."}],"balance_after":20000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-21-004638","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495421004638/section16.xml","form_type":"4"}},{"id":2988529,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-11-09T18:01:01.000Z","date":"2020-11-09","kind":"other","acquired":false,"shares":4262,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":4262},"source":{"system":"sec-edgar","filing":"0001654954-20-012045","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420012045/section16.xml","form_type":"4"}},{"id":2988528,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-11-09T18:01:01.000Z","date":"2020-11-09","kind":"other","acquired":true,"shares":4262,"price":4,"value":17048.0,"ownership":{"direct":true},"balance_after":12786,"source":{"system":"sec-edgar","filing":"0001654954-20-012045","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420012045/section16.xml","form_type":"4"}},{"id":3007497,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2020-10-14T15:50:06.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":20000,"derivative":{"exercise_price":7.44,"expiration_date":"2030-10-13","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-20-011139","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420011139/section16.xml","form_type":"4"}},{"id":3086887,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-08T16:30:09.000Z","date":"2020-07-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning July 6, 2020."}],"balance_after":150000,"derivative":{"exercise_price":0.6216,"expiration_date":"2030-07-06","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001551986-20-000223","document":"wf-form4_159424019563681.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198620000223/wf-form4_159424019563681.xml","form_type":"4"}},{"id":3092813,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-02T16:22:57.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-04","underlying":"Common stock","underlying_shares":84800},"source":{"system":"sec-edgar","filing":"0001551986-20-000203","document":"wf-form4_159372134719404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198620000203/wf-form4_159372134719404.xml","form_type":"4"}},{"id":3092812,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-07-02T16:22:57.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":84800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":84800,"source":{"system":"sec-edgar","filing":"0001551986-20-000203","document":"wf-form4_159372134719404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198620000203/wf-form4_159372134719404.xml","form_type":"4"}},{"id":3164024,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Warrant","published_at":"2020-05-04T18:48:49.000Z","date":"2020-05-04","kind":"purchase","acquired":true,"shares":848,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The purchase price of the warrant was included with the purchase price of the Series A Convertible Preferred Stock. The Series A Preferred Warrant is convertible into Series A Preferred Stock on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of the warrant was included with the purchase price of the Series A Convertible Preferred Stock. The Series A Preferred Warrant is convertible into Series A Preferred Stock on a 1-for-1 basis."}],"balance_after":84800,"derivative":{"exercise_date":"2020-05-04","expiration_date":"2025-05-04","underlying":"Common stock","underlying_shares":84800},"source":{"system":"sec-edgar","filing":"0001551986-20-000117","document":"wf-form4_158863251060904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198620000117/wf-form4_158863251060904.xml","form_type":"4"}},{"id":3164023,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-05-04T18:48:49.000Z","date":"2020-05-04","kind":"purchase","acquired":true,"shares":848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The purchase price of the Series A Convertible Preferred Stock was $58.94 per share. The Series A Preferred Stock is convertible into Common Stock upon stockholder approval on a 1-for-100 basis, with no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The purchase price of the Series A Convertible Preferred Stock was $58.94 per share. The Series A Preferred Stock is convertible into Common Stock upon stockholder approval on a 1-for-100 basis, with no expiration date."}],"balance_after":84800,"derivative":{"exercise_date":"2020-05-04","underlying":"Common stock","underlying_shares":84800},"source":{"system":"sec-edgar","filing":"0001551986-20-000117","document":"wf-form4_158863251060904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198620000117/wf-form4_158863251060904.xml","form_type":"4"}},{"id":3164021,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-04T18:04:25.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in full on 4/24/2020."}],"balance_after":25000,"derivative":{"exercise_price":0.6,"exercise_date":"2020-04-24","expiration_date":"2030-04-24","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001551986-20-000109","document":"wf-form4_158862984124506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198620000109/wf-form4_158862984124506.xml","form_type":"4"}},{"id":3271450,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2020-02-14T18:19:36.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested"}],"balance_after":11389,"derivative":{"exercise_price":3.16,"expiration_date":"2030-02-12","underlying":"Common Shares","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001654954-20-001652","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420001652/section16.xml","form_type":"4"}},{"id":3312726,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-13T08:30:54.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":4262,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":4262,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":4262},"source":{"system":"sec-edgar","filing":"0001654954-20-000335","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420000335/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3312725,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-13T08:30:54.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":6393,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":6393,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":6393},"source":{"system":"sec-edgar","filing":"0001654954-20-000335","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420000335/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3312724,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-01-13T08:30:54.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":8524,"price":4.11,"value":35033.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":8524,"source":{"system":"sec-edgar","filing":"0001654954-20-000335","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420000335/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3313790,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T14:11:21.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":4262,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":4262,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":4262},"source":{"system":"sec-edgar","filing":"0001654954-20-000267","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420000267/section16.xml","form_type":"4"}},{"id":3313789,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T14:11:21.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":6393,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":6393,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":6393},"source":{"system":"sec-edgar","filing":"0001654954-20-000267","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420000267/section16.xml","form_type":"4"}},{"id":3313788,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-01-10T14:11:21.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":8524,"price":4.11,"value":35033.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."}],"balance_after":8524,"source":{"system":"sec-edgar","filing":"0001654954-20-000267","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000165495420000267/section16.xml","form_type":"4"}},{"id":3502912,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T21:13:00.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the reporting person of stock options under the Innovate Biopharmaceuticals, Inc. 2012 Omnibus Incentive Plan. These stock options vest in 36 equal monthly installments."}],"balance_after":25000,"derivative":{"exercise_price":1.28,"expiration_date":"2029-05-31","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001551986-19-000072","document":"wf-form4_155969716584228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198619000072/wf-form4_155969716584228.xml","form_type":"4"}},{"id":3740063,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114944,"kind":"person","name":"JOHNSON LORIN K","position":1,"cik":"0001053878","reported_name":"JOHNSON LORIN K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-07T17:21:49.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the reporting person of stock options under the Innovate Biopharmaceuticals, Inc. 2012 Omnibus Incentive Plan.  These stock options vest in 36 equal monthly installments."}],"balance_after":25000,"derivative":{"exercise_price":2.41,"expiration_date":"2028-12-04","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001551986-18-000069","document":"wf-form4_154422129158239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053878/000155198618000069/wf-form4_154422129158239.xml","form_type":"4"}}]}